Hsbc Holdings PLC Increases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Hsbc Holdings PLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 17.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 752,488 shares of the company’s stock after buying an additional 109,951 shares during the period. Hsbc Holdings PLC owned approximately 0.16% of GE HealthCare Technologies worth $58,720,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of GEHC. US Bancorp DE increased its holdings in GE HealthCare Technologies by 83.4% during the fourth quarter. US Bancorp DE now owns 146,524 shares of the company’s stock valued at $11,329,000 after buying an additional 66,638 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in shares of GE HealthCare Technologies by 23.7% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 97,127 shares of the company’s stock worth $7,510,000 after purchasing an additional 18,634 shares in the last quarter. Global Assets Advisory LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter worth $4,273,000. Vanguard Group Inc. lifted its position in GE HealthCare Technologies by 9.2% during the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after purchasing an additional 4,107,746 shares in the last quarter. Finally, Mather Group LLC. purchased a new position in GE HealthCare Technologies during the first quarter valued at $106,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 2.4 %

NASDAQ GEHC opened at $90.62 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The firm has a market capitalization of $41.36 billion, a price-to-earnings ratio of 26.50, a PEG ratio of 3.26 and a beta of 1.17. The company has a fifty day moving average of $83.64 and a two-hundred day moving average of $83.31.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.92 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. The ex-dividend date of this dividend was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Stifel Nicolaus started coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective on the stock. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target for the company. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective on the stock. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Wednesday. Six investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $95.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.